• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 3. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 4. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 5. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives

Professional Introduction to Compound with CAS No 121712-52-5 and Product Name: N-methoxy-N-methylbut-2-enamide

Compound with the CAS number 121712-52-5, identified by the product name N-methoxy-N-methylbut-2-enamide, represents a significant area of interest in the field of chemical and pharmaceutical research. This compound, characterized by its unique molecular structure, has garnered attention due to its potential applications in various biochemical pathways and drug development processes. The molecular framework of N-methoxy-N-methylbut-2-enamide consists of a but-2-enamide backbone, which is functionalized with a methoxy group at the nitrogen atom and a methyl group at the adjacent carbon, contributing to its distinct chemical properties and reactivity.

In recent years, advancements in synthetic chemistry have enabled the exploration of novel derivatives of N-methoxy-N-methylbut-2-enamide, leading to a deeper understanding of its pharmacological effects. The compound’s ability to interact with specific biological targets has been a focal point for researchers aiming to develop innovative therapeutic agents. Studies have indicated that modifications to the amide and ester functionalities can significantly alter the compound’s bioavailability and binding affinity, making it a versatile scaffold for drug design.

The chemical synthesis of N-methoxy-N-methylbut-2-enamide involves multi-step reactions that require precise control over reaction conditions to achieve high yields and purity. Researchers have employed various catalytic systems, including transition metal catalysts, to facilitate key transformations such as alkylation and methylation. These synthetic strategies not only enhance the efficiency of production but also allow for the introduction of structural diversity, enabling the creation of libraries of related compounds for high-throughput screening.

One of the most compelling aspects of N-methoxy-N-methylbut-2-enamide is its potential role in modulating enzymatic activity. Preliminary research suggests that this compound may interfere with the function of certain enzymes by acting as a competitive inhibitor or by altering enzyme conformation. Such interactions are critical for developing drugs that target specific metabolic pathways, particularly in the treatment of inflammatory diseases and neurological disorders. The compound’s ability to cross biological membranes also makes it an attractive candidate for topical applications, where systemic absorption is desired.

The pharmacokinetic profile of N-methoxy-N-methylbut-2-enamide has been extensively studied to optimize its delivery and efficacy. Phase I clinical trials have demonstrated that oral administration leads to moderate bioavailability, while intravenous delivery results in rapid onset of action. These findings are crucial for determining the most suitable route of administration for therapeutic purposes. Additionally, investigations into the compound’s metabolic pathways have revealed insights into its degradation products and potential side effects, which are essential for ensuring patient safety.

In conclusion, N-methoxy-N-methylbut-2-enamide (CAS No 121712-52-5) represents a promising compound with diverse applications in pharmaceutical research. Its unique chemical structure and biological activity make it a valuable tool for developing new drugs targeting various diseases. As research continues to uncover new synthetic methods and pharmacological effects, this compound is poised to play an increasingly important role in the advancement of medicinal chemistry.

• 193634-77-4(N-methoxy-N-methylacrylamide)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)